+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neuromodulation Devices Market by Device Type, Technology, Therapeutic Area, End User - Global Forecast to 2030- Product Image
Neuromodulation Devices Market by Device Type, Technology, Therapeutic Area, End User - Global Forecast to 2030- Product Image
Sale

Neuromodulation Devices Market by Device Type, Technology, Therapeutic Area, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666253
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neuromodulation Devices Market grew from USD 9.79 billion in 2024 to USD 11.16 billion in 2025. It is expected to continue growing at a CAGR of 13.65%, reaching USD 21.10 billion by 2030.

Setting the Stage for Neuromodulation Breakthroughs

The field of neuromodulation is entering a new era defined by technological breakthroughs, expanding therapeutic applications, and evolving healthcare dynamics. As clinical evidence continues to validate the efficacy of electrical and magnetic stimulation techniques, healthcare providers and device manufacturers are responding with unprecedented investment and innovation. This report offers an in-depth examination of the forces shaping the neuromodulation market, equipping stakeholders with clarity on where the most compelling opportunities lie.

In tracing the trajectory of this sector, we uncover how shifting regulatory frameworks, advancements in closed loop systems, and growing patient demand for minimally invasive interventions are converging to reshape treatment paradigms. By synthesizing diverse data sources and expert perspectives, this research underscores the critical inflection points that will determine competitive positioning and clinical adoption in the years ahead. Professionals across the innovation, clinical, and investment spectrums will find actionable intelligence here, enabling informed decisions in a field where precision and timing are everything.

Evolving Forces Reshaping the Neuromodulation Arena

Over the past decade, we have witnessed a radical transformation in how neuromodulation therapies are conceived, developed, and delivered. Advances in device miniaturization, sensor integration, and algorithmic stimulation protocols have accelerated the migration from open loop platforms to sophisticated closed loop systems that adjust therapy in real time. Concurrently, a surge in digital health integration and remote monitoring is bridging the gap between clinician and patient, fostering personalized care pathways.

Moreover, novel indications ranging from mood disorders to chronic pain are driving expansion beyond traditional neurosurgical applications. Collaborations between medical device companies, software developers, and academic institutions are yielding hybrid solutions that combine hardware precision with predictive analytics. Consequently, this confluence of capabilities is not just evolving the product landscape-it is redefining clinical standards and patient expectations across therapeutic areas.

United States Tariffs Altering the Cost Dynamics in 2025

The United States’ decision to implement additional tariffs on key neuromodulation components in 2025 has introduced new cost pressures across the value chain. Device manufacturers reliant on imported electronic modules and specialty materials are experiencing margin compression, prompting a reassessment of sourcing strategies and potential shifts toward domestic production or nearshoring. Healthcare providers, in turn, may encounter higher procedural costs, with implications for reimbursement negotiations and capital expenditure planning.

In response, partnerships between component suppliers and device OEMs are intensifying, with a focus on joint investment in localized supply networks. Some leading companies are fast‐tracking qualification of alternative material sources to mitigate tariff impact. While these measures may stabilize pricing in the medium term, the tariff environment underscores the importance of agile procurement practices and proactive policy engagement to safeguard both innovation pipelines and patient access.

Decoding Market Segments to Unveil Growth Drivers

A nuanced understanding of the neuromodulation market emerges when examining device type, technology, therapeutic area, and end user perspectives together. Invasive devices encompass deep brain stimulators designed to target neurological circuits, sacral nerve stimulators for bowel and bladder control, spinal cord stimulators that alleviate chronic pain, and vagus nerve stimulators employed in epilepsy and depression management. Noninvasive modalities include transcranial direct current stimulation that modulates cortical excitability, transcranial magnetic stimulation delivering focused magnetic pulses, and transcutaneous electrical nerve stimulation used predominantly in pain therapy.

Aligned with this hardware segmentation, technology approaches are classified as open loop systems delivering pre‐programmed stimulation patterns or closed loop platforms that adapt in real time to physiological feedback. From a therapeutic standpoint, neuromodulation interventions address depression by targeting neural pathways linked to mood, epilepsy through seizure prevention, movement disorders via basal ganglia modulation, and pain management by disrupting nociceptive signaling. End users span ambulatory surgical centers performing high‐volume procedures, clinical practices integrating neuromodulation into multidisciplinary care, home care settings facilitating patient‐managed therapy, hospitals deploying advanced surgical suites, and research institutes pioneering next‐generation applications. This integrated lens reveals which combinations of device, technology, indication, and care setting drive commercialization momentum and clinical adoption.

Regional Nuances Driving Neuromodulation Adoption Worldwide

Regional dynamics in the neuromodulation market reveal distinct adoption patterns and regulatory influences. In the Americas, robust reimbursement frameworks and established referral networks have accelerated uptake of deep brain and spinal cord stimulators. Meanwhile, a growing emphasis on outpatient care is fostering expansion of home‐based transcutaneous modalities. Across Europe, Middle East & Africa, diverse regulatory landscapes coexist with rising investment in research infrastructure, enabling pilot programs in closed loop technologies and emerging indications such as treatment‐resistant depression.

In the Asia-Pacific region, demographic shifts and expanding healthcare budgets are catalyzing demand for cost‐effective, noninvasive stimulation devices. Countries with rapidly aging populations are prioritizing movement disorder therapies, while telemedicine integration supports remote monitoring and follow‐up care. Taken together, these regional nuances underscore the need for tailored market entry strategies that align device portfolios, regulatory plans, and distribution models with localized healthcare priorities.

Competitive Landscape and Leading Innovators in Focus

The competitive landscape is characterized by established medtech giants and agile innovators driving incremental and disruptive advancements. Leading players are investing heavily in proprietary closed loop algorithms and implantable battery technologies to extend device longevity and optimize therapeutic outcomes. Concurrently, emerging companies are leveraging partnerships with digital health firms to introduce predictive analytics and remote patient engagement platforms. Collaborations with academic medical centers are fueling clinical trial pipelines, particularly for novel indications where real‐world evidence remains limited.

Strategic M&A activity is also reshaping market dynamics, as firms seek to augment their portfolios with complementary technologies and geographic reach. Licensing agreements for neuromodulation IP are becoming more commonplace, enabling mid‐sized device manufacturers to access advanced stimulation protocols without incurring exhaustive R&D timelines. As competition intensifies, the ability to deliver integrated hardware‐software solutions and to demonstrate compelling clinical and economic value will distinguish the market leaders.

Strategic Imperatives for Industry Leadership Advancement

To thrive in a landscape defined by rapid technological evolution and regulatory complexity, industry leaders must adopt a multi‐pronged strategic approach. First, prioritizing modular platform development will enable faster iteration cycles and seamless integration of closed loop capabilities. Second, expanding partnerships with component suppliers in low‐tariff jurisdictions can mitigate cost volatility and protect margins. Third, cultivating alliances with payers and provider networks will accelerate reimbursement approvals and drive broader clinical adoption.

Furthermore, investing in robust real‐world data collection through digital health platforms will strengthen value propositions for new indications. Leaders should also pursue targeted geographic expansion in regions with favorable regulatory frameworks and untapped demand, leveraging local partnerships to navigate market entry. Lastly, establishing clear internal governance for regulatory and quality processes will ensure compliance and expedite time‐to‐market for next‐generation devices.

Rigorous Research Methodology Underpinning Insights

This research employs a rigorous mixed‐methods approach to ensure the validity and reliability of findings. Secondary research involved a comprehensive review of public filings, peer‐reviewed journals, regulatory databases, and industry white papers to map historical trends and current best practices. Primary research comprised in‐depth interviews with over 30 key opinion leaders, including neurosurgeons, device engineers, regulatory specialists, and payers, providing nuanced perspectives on adoption barriers and innovation pathways.

Quantitative data were triangulated across multiple vendor databases to refine segmentation frameworks and validate market share insights by device type, technology, therapeutic area, and end user. Regional analyses were corroborated through collaboration with in‐country analysts to capture localized regulatory requirements and reimbursement landscapes. The methodological rigor of this study ensures that stakeholders receive a holistic, data‐driven view of the neuromodulation market, supporting confident strategic decisions.

Concluding Perspectives on Neuromodulation’s Emerging Horizon

As neuromodulation emerges as a cornerstone of advanced therapeutic interventions, stakeholders are presented with both unprecedented opportunities and complex challenges. Sustainable growth will hinge on the ability to navigate tariff environments, optimize supply chains, and demonstrate clear clinical and economic value. Segmentation analysis highlights where device innovation and therapeutic demand intersect, while regional insights reveal where customized strategies can unlock new markets.

Looking ahead, the integration of artificial intelligence and enhanced biomaterials promises to deepen the capabilities of neuromodulation platforms. However, realizing these advances will require cohesive collaboration across device manufacturers, clinical researchers, regulatory bodies, and payers. By synthesizing these diverse perspectives, this report offers a roadmap for guiding successful product development, market entry, and commercialization in a field poised for transformational growth.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Device Type
    • Invasive Devices
      • Deep Brain Stimulators
      • Sacral Nerve Stimulators
      • Spinal Cord Stimulators
      • Vagus Nerve Stimulators
    • Noninvasive Devices
      • Transcranial Direct Current Stimulation
      • Transcranial Magnetic Stimulation
      • Transcutaneous Electrical Nerve Stimulation
  • Technology
    • Closed Loop
    • Open Loop
  • Therapeutic Area
    • Depression
    • Epilepsy
    • Movement Disorders
    • Pain Management
  • End User
    • Ambulatory Surgical Centers
    • Clinics
    • Home Care Settings
    • Hospitals
    • Research Institutes
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Nevro Corp
  • LivaNova PLC
  • BIOTRONIK SE & Co. KG
  • Cochlear Limited
  • Axonics Modulation Technologies, Inc.
  • Inspire Medical Systems, Inc.
  • ElectroCore, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neuromodulation Devices Market, by Device Type
8.1. Introduction
8.2. Invasive Devices
8.2.1. Deep Brain Stimulators
8.2.2. Sacral Nerve Stimulators
8.2.3. Spinal Cord Stimulators
8.2.4. Vagus Nerve Stimulators
8.3. Noninvasive Devices
8.3.1. Transcranial Direct Current Stimulation
8.3.2. Transcranial Magnetic Stimulation
8.3.3. Transcutaneous Electrical Nerve Stimulation
9. Neuromodulation Devices Market, by Technology
9.1. Introduction
9.2. Closed Loop
9.3. Open Loop
10. Neuromodulation Devices Market, by Therapeutic Area
10.1. Introduction
10.2. Depression
10.3. Epilepsy
10.4. Movement Disorders
10.5. Pain Management
11. Neuromodulation Devices Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Home Care Settings
11.5. Hospitals
11.6. Research Institutes
12. Americas Neuromodulation Devices Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Neuromodulation Devices Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Neuromodulation Devices Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Medtronic plc
15.3.2. Abbott Laboratories
15.3.3. Boston Scientific Corporation
15.3.4. Nevro Corp
15.3.5. LivaNova PLC
15.3.6. BIOTRONIK SE & Co. KG
15.3.7. Cochlear Limited
15.3.8. Axonics Modulation Technologies, Inc.
15.3.9. Inspire Medical Systems, Inc.
15.3.10. ElectroCore, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NEUROMODULATION DEVICES MARKET MULTI-CURRENCY
FIGURE 2. NEUROMODULATION DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. NEUROMODULATION DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NEUROMODULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NEUROMODULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NEUROMODULATION DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CLOSED LOOP, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OPEN LOOP, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 48. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 49. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 51. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 54. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 55. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 57. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 79. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 80. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 82. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 84. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 85. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 86. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 88. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 90. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 91. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 92. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 94. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 96. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 97. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 98. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 100. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 102. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 103. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 104. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 106. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 108. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 109. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 110. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 112. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 115. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 116. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 118. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 132. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 133. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 134. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 136. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 144. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 145. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 146. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 148. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 150. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 151. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 152. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 154. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 156. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 157. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 158. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 160. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 162. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 163. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 164. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 166. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 168. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 169. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 170. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 172. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 174. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 175. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 176. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 178. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 186. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 187. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 188. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 190. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 192. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 193. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 194. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 196. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 198. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 199. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 200. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 202. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 210. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 211. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 212. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 213. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 215. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 217. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 218. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 219. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 221. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 223. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 224. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 225. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 227. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 239. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 245. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 247. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 248. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 249. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 251. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 257. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 269. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 275. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 281. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. NEUROMODULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
TABLE 283. NEUROMODULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this Neuromodulation Devices market report include:
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Nevro Corp
  • LivaNova PLC
  • BIOTRONIK SE & Co. KG
  • Cochlear Limited
  • Axonics Modulation Technologies, Inc.
  • Inspire Medical Systems, Inc.
  • ElectroCore, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 11.16 Billion
Forecasted Market Value ( USD ) by 2030 $ 21.1 Billion
Compound Annual Growth Rate13.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Neuromodulation Devices Market Size, Share & Trends Analysis By Product (Spinal Cord Stimulators, Deep Brain Stimulators), By Application (Parkinson's Disease, Chronic Pain), By End-use, By Region, 2025 - 2030 - Product Image

Neuromodulation Devices Market Size, Share & Trends Analysis By Product (Spinal Cord Stimulators, Deep Brain Stimulators), By Application (Parkinson's Disease, Chronic Pain), By End-use, By Region, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Neuromodulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Neuromodulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Neuromodulation Market by Product Type, Application, End User, Technology - Global Forecast to 2030 - Product Image

Neuromodulation Market by Product Type, Application, End User, Technology - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Neuromodulation Devices Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Neuromodulation Devices Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 91 Pages
  • Global
From
Neuromodulation Devices Market by Product, by Application, by End-User, and By Region - Product Image

Neuromodulation Devices Market by Product, by Application, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.